RBL LLC Announces Launch of SteerBio with an up to $18.2 Million Federal Award to Pioneer a Curative Therapy for Lymphedema

HOUSTON, March 5, 2026 /PRNewswire/ -- RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies, today announced that portfolio company SteerBio, a biotech startup developing a first-of-its-kind regenerative treatment aimed at restoring damaged lymphatic vessels and potentially curing lymphedema, today announced its official launch and has been awarded up to $18.2 million in funding from the Advanced Research Projects Agency for Health (ARPA-H).